Literature DB >> 16849415

Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves.

Fred W Lafferty1, Clive R Hamlin, Kristin R Corrado, Andrew Arnold, Jerry M Shuck.   

Abstract

CONTEXT: In patients with primary hyperparathyroidism (PHP), one expects to find a serum PTH in the high or high-normal range. The presence of a low-normal PTH in PHP can be difficult to explain.
OBJECTIVE: Our objective was to investigate the cause of a low-normal serum PTH in a patient with PHP. PATIENT: A 57-yr-old asymptomatic white female from the private practice of F.W.L. presented with an 8-yr history of a rising serum calcium from 10.5-11.6 mg/dl (2.63-2.88 mmol/liter) and a low-normal serum intact PTH of 29.2 pg/ml. After localization of a parathyroid adenoma by [(18)F]fluorodesoxyglucose positron emission tomography scanning, a 120-mg parathyroid adenoma was removed with the achievement of normocalcemia for the subsequent 2 yr.
METHODS: Routine pre- and postoperative serum intact PTH assays were preformed at both the Quest Diagnostics regional laboratory in Pittsburgh, Pennsylvania, and at the Quest Diagnostics Nichols Institute in California. In addition, intact, biointact, and C-terminal assays were measured in undiluted, 1:2 diluted, and 1:4 diluted sera at the Nichols Institute. PTH gene sequence analysis was performed from DNA extracted both from the parathyroid adenoma and the patient's peripheral blood leukocytes.
RESULTS: Dilution, with correction for the dilution factor, of the preoperative serum produced a progressive rise in the intact, biointact, and the C-terminal assays, whereas no dilution effect was seen in postoperative serum. No intragenic mutations in the pre-pro-PTH coding region were found in either the parathyroid adenoma or matched blood DNA samples.
CONCLUSIONS: The discordant preoperative immunoassay curves with dilution could not be explained by the adenoma producing a mutated PTH. Furthermore, an autoantibody against the PTH produced by the adenoma is ruled out by the prompt loss of the dilution effect in the three PTH assays within 1 wk of the adenoma's excision. A posttranslational effect on the PTH molecule within the adenoma remains a possible explanation for the discordant immunoassay curves. Our report emphasizes that one cannot always rule out PHP because of a low-normal serum intact or biointact PTH. Repeated PTH measurements after serum dilution in suspected cases of PHP with low-normal PTH levels may be a useful method for detecting atypical forms of PTH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849415     DOI: 10.1210/jc.2006-0273

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Lessons from second- and third-generation parathyroid hormone assays in primary hyperparathyroidism.

Authors:  J C Souberbielle; P Boudou; C Cormier
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

2.  Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl.

Authors:  Amanda D Benaderet; Amy M Burton; Roderick Clifton-Bligh; Ambika P Ashraf
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

3.  Normal parathyroid hormone levels in a diabetic patient with parathyroid adenoma.

Authors:  Nese Ersoz Gulcelik; Fani Bozkurt; Gaye Güler Tezel; Volkan Kaynaroglu; Tomris Erbas
Journal:  Endocrine       Date:  2008-12-31       Impact factor: 3.633

4.  Multigland disease and slower decline in intraoperative PTH characterize mild primary hyperparathyroidism.

Authors:  David F Schneider; Jocelyn F Burke; Kristin A Ojomo; Nicholas Clark; Haggi Mazeh; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2013-08-14       Impact factor: 5.344

5.  Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range.

Authors:  Fabio Medas; Enrico Erdas; Giulia Loi; Francesco Podda; Lucia Barca; Giuseppe Pisano; Pietro Giorgio Calò
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

6.  Intraoperative parathormone monitoring to predict operative success in patients with normohormonal hyperparathyroidism.

Authors:  Heather Stuart; Basem Azab; Omar Picado Roque; Janice Pasieka; John I Lew
Journal:  Can J Surg       Date:  2022-07-28       Impact factor: 2.840

7.  Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.

Authors:  Angela Gurrado; Andrea Marzullo; Germana Lissidini; Agostino Lippolis; Domenico Rubini; Gaetano Lastilla; Mario Testini
Journal:  World J Surg Oncol       Date:  2008-02-21       Impact factor: 2.754

8.  Serum Calcium to Phosphorous (Ca/P) Ratio Is a Simple, Inexpensive, and Accurate Tool in the Diagnosis of Primary Hyperparathyroidism.

Authors:  Bruno Madeo; Elda Kara; Katia Cioni; Silvia Vezzani; Tommaso Trenti; Daniele Santi; Manuela Simoni; Vincenzo Rochira
Journal:  JBMR Plus       Date:  2017-11-02

9.  Case report: incidental parathyroid adenoma in a Chinese diabetic patient with hypercalcemia and normal parathyroid hormone levels.

Authors:  Can Pang; Youben Fan; Huizheng Zhang; Haoyong Yu; Bomin Guo; Jie Kang; Xianzhao Deng; Yuqian Bao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.